Market Overview
According to fortune business insights, the global human organoids market size was valued at USD 1.18 billion in 2025. The market is projected to grow from USD 1.44 billion in 2026 to USD 5.71 billion by 2034, exhibiting a CAGR of 18.8% during the forecast period. North America dominated the global human organoids market with a share of 41.52% in 2025.
The analysis shows that the market growth is attributed to increasing investments in organoid-based drug discovery and collaboration between pharmaceutical companies, biotechnology firms, and academic institutes. Human organoids, which are 3D mini-tissues grown from stem cells, are increasingly used to study disease, test drugs, and support precision medicine.
Major Players Profiled in the Market Report:
Segments
Increasingly Growing Demand for Supplements, Media & Reagents to Drive Segment Growth
Based on product, the market is segmented into organoid models and supplements, media & reagents. The supplements, media & reagents segment accounted for the largest market share as labs increasingly adopt organoids for routine screening, driving the demand for media and reagents to maintain the models.
Increasing Drug Discovery & Development Globally to Drive Segment’s Growth
By application, the market is categorized into drug discovery & development, disease modeling, personalized medicine, and others. The drug discovery & development segment holds the largest market share, driven by increasing efforts from pharmaceutical companies utilizing organoids in their research.
Increasing Prevalence of Neurological Diseases to Accelerate Brain Model Segment
By model type, the market is classified into brain model, liver model, intestinal model, lung model, pancreatic model, and others. The brain model segment accounted for the major market share, as these models are critical for neurodevelopment studies and research into neurodegenerative diseases.